GenoLogics announces the release of ProteusLIMS™ - the first laboratory information management system (LIMS) software designed to increase the productivity and efficiency of proteomics laboratories
GenoLogics, the leader in proteomics laboratory information management systems (LIMS), announced today the release of ProteusLIMS version 1.0. ProteusLIMS is the first commercially available LIMS that specializes in meeting the needs of researchers involved in the study of proteomics. ProteusLIMS is an end-to-end product suite that provides a robust laboratory data integration solution.
Victoria, BC, Canada (PRWEB) May 14, 2004
GenoLogics, the leader in proteomics laboratory information management systems (LIMS), announced today the release of ProteusLIMS version 1.0. ProteusLIMS is the first commercially available LIMS that specializes in meeting the needs of researchers involved in the study of proteomics. ProteusLIMS is an end-to-end product suite that provides a robust laboratory data integration solution.
ProteusLIMS is designed to manage the large volumes of data generated in the emerging field of proteomics research, where scientists undertake complex studies of proteins to develop disease diagnostics and find new targets for drug development. “Proteomics is the next big thing after genomics,” says GenoLogics CEO James DeGreef. “Proteomics technologies provide the most direct way to identify and study drug targets, so we expect a wide application of ProteusLIMS within the pharmaceutical industry”.
An innovative data management solution for proteomics research labs
In proteomics, researchers are faced with enormous amounts of data and increasingly complex and disintegrated research instruments. GenoLogicsÂ’ ProteusLIMS manages data from all parts of the research process, as well as the research process itself, enabling higher productivity. With ProteusLIMS, researchers have more time to focus on their research. A unique feature of ProteusLIMS is that it has been designed and built from the ground up to be compatible with any computing platform and scientific instrumentation platform.
About Proteomics
Proteomics has been defined by the World Health Organization as “the development and application of techniques to investigate the protein products of the genome and how they interact to determine biological functions”. Proteins carry out about 99% of the chemical reactions in cells and are the building blocks of many of the structures in cells. It is important to understand proteins so that drugs can target them properly.
About GenoLogics
GenoLogics develops LIMS for the life sciences market, specializing in the emerging field of proteomics research. As proteomics technologies progress from the research lab into commercial drug discovery (biotechnology and pharmaceutical) and clinical diagnostics applications, GenoLogics is continuing to develop additional functionality in its software to meet these unique needs. GenoLogics customers are among most respected in the life sciences community.
